2024 ASCO® Annual Meeting Insights Hub

Meeting coverage & Vumedi’s exclusive highlights, all in one place.

 

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and Adjuvant Treatments, 1L Metastatic & Anti-PD-1 Refractory Disease"

322 views
July 5, 2024
0 Comments
Login to view comments. Click here to Login